This article is more than 5 years old. Information may no longer be current.
Top stories in gastroenterology: Eating fish may decrease colorectal cancer risk, positive results of prep-free colon cancer screening device
Click Here to Manage Email Alerts
Among the top stories in gastroenterology last week were a study that suggested eating fish as part of a regular diet may decrease the risk for colorectal cancer and Check-Cap’s report that its prep-free colon cancer screening device demonstrated efficacy and safety.
Other highlights included a study that found costs of inflammatory bowel disease-related care have increased over the last 5 years and are driven by the cost of therapeutics, research that determined deficiencies in micronutrients (eg, zinc, copper and vitamin B12) are common in patients with celiac disease and study results that suggested gut microbiota changes bile acid composition and affects phenotypic features of inflammatory bowel disease.
Eating fish may decrease colorectal cancer risk
Eating fatty or lean fish or shellfish as part of a regular diet may help decrease the risk for colorectal cancer, according to study results. Read more.
Positive results of a prep-free colon cancer screening device reported
Check-Cap announced positive final results from its completed post-CE approval study evaluating the efficacy and safety of the C-Scan system. Read more.
Therapies, disease features driving inflammatory bowel disease cost increases
Costs of inflammatory bowel disease-related care have increased over the last 5 years, driven by the cost of therapeutics, like biologics and steroids, and health care services associated with relapse in disease, according to study results. Read more.
Micronutrient deficiencies common in celiac disease
Deficiencies in micronutrients like zinc, copper and vitamin B12 are common in patients with celiac disease, according to study results. Read more.
Gut microbiota changes bile acid composition, affects phenotypic features of inflammatory bowel disease
Higher levels of bile acid-metabolizing microbiota correlated significantly with type and location of disease and mucosal inflammation in patients with inflammatory bowel disease, according to a study presented at Digestive Disease Week. Read more.